Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases
Alberto Ruano-Ravina, María Torres-Durán, Karl T. Kelsey, Isaura Parente-Lamelas, Virginia Leiro-Fernández, Ihab Abdulkader, José Abal-Arca, Carmen Montero-Martínez, Iria Vidal-García, Margarita Amenedo, Olalla Castro-Añón, Antonio Golpe-Gómez, Javier González-Barcala, Cristina Martínez, Rosirys Guzmán-Taveras, Mariano Provencio, María José Mejuto-Martí, Alberto Fernández-Villar and Juan Miguel Barros-Dios
Source: Eur Respir J 2016; 48: 1462-1470
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alberto Ruano-Ravina, María Torres-Durán, Karl T. Kelsey, Isaura Parente-Lamelas, Virginia Leiro-Fernández, Ihab Abdulkader, José Abal-Arca, Carmen Montero-Martínez, Iria Vidal-García, Margarita Amenedo, Olalla Castro-Añón, Antonio Golpe-Gómez, Javier González-Barcala, Cristina Martínez, Rosirys Guzmán-Taveras, Mariano Provencio, María José Mejuto-Martí, Alberto Fernández-Villar and Juan Miguel Barros-Dios. Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases. Eur Respir J 2016; 48: 1462-1470
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Is residential radon associated with mutations in drivers genes in never smokers lung cancer cases? The case of EGFR and ALK Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort Source: Eur Respir J 2012; 40: 177-184 Year: 2012
Asbestos-related lung cancers are rarely associated with ALK , ROS1 and RET rearrangements Source: Eur Respir J, 51 (3) 1702605; 10.1183/13993003.02605-2017 Year: 2018
K-RAS oncogenic mutations in patients with nonsmall cell lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
Study of NF2 and P16/CDKN2A genes in lung cancer in patients occupationally exposed to asbestos Source: Eur Respir J 2004; 24: Suppl. 48, 146s Year: 2004
Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014
Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013
Mutation of TP53 and KRAS , and loss of p16ink4a and p14arf expression in lung cancers in relation to tobacco smoke Source: Eur Respir J 2005; 26: Suppl. 49, 93s Year: 2005
Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013
Clinical relevance of p53 and K-ras mutations in nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001
Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001
Germline mutations in young never-smokers with lung adenocarcinoma Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
Association between lung cancer somatic mutations and occupational exposure in never-smokers Source: Eur Respir J, 50 (4) 1700716; 10.1183/13993003.00716-2017 Year: 2017
Model for predicting EGFR mutation status in lung cancer Source: Breathe, 15 (4) 340; 10.1183/20734735.0250-2019 Year: 2019
Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018
Characterization of patients with non-small cell lung cancer (NSCLC) relative to its EGFR mutational status Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011
p53 gene mutations in lung cancer in Korean Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation Source: Eur Respir J 2011; 37: 624-631 Year: 2011
Croatian Caucasians with lung adenocarcinoma harbouring EGFR mutations with and without brain metastasis Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
The association between residential radon concentration and lung cancer Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011